BioHarvest Sciences said it has partnered with former National Football League (NFL) wide receiver Yo Murphy to supply its VINIA nutraceutical supplement to aspiring football players preparing for this month’s NFL Scouting Combine and the upcoming 2023 NFL Draft.
VINIA has been clinically proven to increase the dilation of arteries, enhance blood flow and delivery of oxygen, and improve physical energy and mental alertness, BioHarvest said in a statement.
These benefits are yielded by the unique piceid resveratrol contained in VINIA, a red grape cell-derived supplement created via Bioharvest's Botanical Synthesis technology, which replicates plant cells in bioreactors, potentially providing a cutting-edge solution for athletes everywhere, the company added.
READ: BioHarvest Sciences announces clinical study in patients with multiple sclerosis-related optic neuritis
Murphy, who was a professional football player for 14 years, is working with leading trainers and nutritionists at the Tampa, Florida-area "House of Athlete" facility to educate trainees on the critical importance of blood flow for their body's overall operating mechanism.
Bioharvest said that VINIA is currently being used by 33 NFL prospects at the facility, 17 of whom have been invited to the 2023 NFL Scouting Combine, with the others training in hopes of an invitation and in anticipation of being noticed by NFL teams ahead of April's draft.
The company said this collaboration with Murphy and the House of Athlete represented an important initiative, which aims to expand health-conscious consumers’ understanding of the broad impacts of improved blood flow.
"As we celebrate this past weekend's Super Bowl and look forward to the NFL Combine and Draft, this is a great time to focus on how to increase the energy levels of young and student-athletes, while keeping them safe and ensuring their wellbeing," Dr Brian Cornblatt, Bioharvest's chief medical officer, commented.
He said that VINIA is the missing link in an athlete's supplement stack, delivering increased blood flow and oxygen to the body’s tissues and organs.
“This powerful combination of benefits provides improved cellular nutrient delivery, improves physical energy and mental alertness, and provides a boost of antioxidant activities helping athletes push their bodies to the limit,” Dr Cornblatt said.
Bioharvest noted that statements about VINIA have not been evaluated by the US Food and Drug Administration. VINIA is not intended to diagnose, treat, cure, or prevent any disease, the company added.
BioHarvest Sciences is a fast-growing biotech firm that has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie